Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer

Launched by MANSOURA UNIVERSITY · Aug 3, 2017

Keywords

ClinConnect Summary

Colorectal cancer (CRC) is considered the third most common type of cancer all over the world and the fourth common cause of cancer-specific mortality.Surgical management for rectal cancer is challenging due to the narrow pelvis and extreme proximity to contiguous organs hence, recurrence rates are commonly reported.

The advent of total mesorectal excision (TME) together with minimally invasive techniques such as laparoscopic colorectal surgery have not only improved surgical results but have also improved surgical technique, operative ability and surgical visibility. Lap TME has been show...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Anesthetically fit patient.
• • 2. Non metastatic pathologically proven rectal cancer (Mid-Low).
• • 3. Patients who received neoadjuvant chemo-radiotherapy will be included
• Exclusion Criteria:
• • 1. Patients with American Society of Anesthesiologist (ASA) score 4 and 5.
• • 2. Patients with cardiac or chest problems that cannot withstand CO2 insufflation.
• • 3. Unresectable tumors (T4) (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation).
• • 4. Obstructed or perforated cancer.
• • 5. Patients with unresectable metastatic rectal cancer.